Patent US2939107A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4953564A Expired / Lapsed US ⏱️ 0.0 years remaining

Screw-in drug eluting lead

Assignee: Medtronic Inc
•
Filing: 1989-08-23
•
Granted: 1990-09-04
•
Expires: 2009-08-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A cardiac pacing lead or other stimulation lead carrying a drug incorporated into a controlled release device. The lead is provided with an extendable fixation helix which is advanceable from the distal end of the lead in order to engage with the tissue to be stimulated and to maintain the distal end of the lead adjacent the tissue to be stimulated. The controlled release device is located within the fixation helix and is extended with the fixation helix when it is advanced out of the distal end of the lead. In its advanced position, the controlled release device is positioned adjacent the distal end of the lead, preferably in a position to contact the tissue to be stimulated.

Inventors

  • 👤 Wendy A. W. Berthelsen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:18
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/057; A61N1/0573; A61N1/0575; A61N1/0565; A61N1/0568

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 332 words
An electrical medical lead comprising: an elongated insulative lead body having a proximal end and a distal end; an elongated conductor, mounted within said lead body, said conductor having a proximal end and a distal end; p1 an electrode assembly mounted at the distal end of said insulative lead body, said electrode assembly comprising an electrode head member having a lumen open to the distal end of said lead body; a fixation helix mounted within said lumen of said head member, said fixation helix having a proximal end and a distal end, said fixation helix mounted in said lumen of said head member such that said helix is advanceable from a first, retracted position within said lumen of said head member in which the dital end of said helix is adjacent the distal end of said lead body to a second, advanced position in which the distal end of said fixation helix projects distally of the distal end of said lead body, said electrode assembly further comprising a drug release device having a proximal end and distal end and having means for releasing a drug contained within said drug release device at least adjacent the dital end of said drug release device, said drug release device mounted to said fixation helix such that when said fixation helix is in said first, retracted position within aid lumen of said head member, the distal end of said drug release device is located within the lumen of said electrode head member and such that when said helix is advanced to said second, extended position, the distal end of said drug release device is adjacent the distal end of said lead body, the distal end of said helix extending distally of the distal end of said drug release device, said electrode assembly further comprising at least one conductive electrode surface coupled to the distal end of said elongated conductor; and means for advancing said fixation helix from said first, retracted position to said second, extended position.
Claim 2
Dependent Claim 332 words
An electrical medical lead comprising: an elongated insulative lead body having a proximal end and a distal end; an elongated conductor, mounted within said lead body, said conductor having a proximal end and a distal end; p1 an electrode assembly mounted at the distal end of said insulative lead body, said electrode assembly comprising an electrode head member having a lumen open to the distal end of said lead body; a fixation helix mounted within said lumen of said head member, said fixation helix having a proximal end and a distal end, said fixation helix mounted in said lumen of said head member such that said helix is advanceable from a first, retracted position within said lumen of said head member in which the dital end of said helix is adjacent the distal end of said lead body to a second, advanced position in which the distal end of said fixation helix projects distally of the distal end of said lead body, said electrode assembly further comprising a drug release device having a proximal end and distal end and having means for releasing a drug contained within said drug release device at least adjacent the dital end of said drug release device, said drug release device mounted to said fixation helix such that when said fixation helix is in said first, retracted position within aid lumen of said head member, the distal end of said drug release device is located within the lumen of said electrode head member and such that when said helix is advanced to said second, extended position, the distal end of said drug release device is adjacent the distal end of said lead body, the distal end of said helix extending distally of the distal end of said drug release device, said electrode assembly further comprising at least one conductive electrode surface coupled to the distal end of said elongated conductor; and means for advancing said fixation helix from said first, retracted position to said second, extended position.
Claim 3
Dependent Claim 19 words
A lead according to claim 1 wherein said electrode surface comprises the distal end of said drug release device.
Claim 4
Dependent Claim 17 words
A lead according to claim 1 or claim 2 wherein said electrode surface comprises said fixation helix.
Claim 5
Dependent Claim 50 words
A lead according to claim 3 wherein said fixation helix is advanced from said first, retracted position to said second, extended position by rotation of said helix, and wherein said means for advancing said helix comprises said elongated conductor, said elongated conductor being rotatably mounted within said electrode head member.
Claim 6
Dependent Claim 30 words
A lead according to claim 1 wherein said drug release device comprises a conductive housing having an elution path for said drug, located at a distal end of said housing.
Claim 7
Dependent Claim 20 words
A lead according to claim 5 wherein said housing comprises a plurality of closely spaced coils of said fixation helix.
Claim 8
Dependent Claim 28 words
A lead according to claim 5 or claim 6 wherein said elution path comprises a porous, sintered metallic structure, sintered to said housing of said drug release device.
Claim 9
Dependent Claim 19 words
A lead according to claim 1 wherein said drug release device comprises a porous member impregnated with said drug.
Claim 10
Dependent Claim 29 words
A lead according to claim 8 wherein said porous member comprises a porous, sintered metal structure, and wherein said porous sintered metal structure is sintered to said fixation helix.

References Cited (Backward Citations)

US356A Cited
US4106512A Cited
US4217913A Cited
US4209019A Cited
US4711251A Cited
US4711251B1 Cited
US4506680A Cited
US4624266A Cited
US4577642A Cited
US4606118A Cited
USH356H Cited
US4819661A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-09-03 1994-03-05 1994-09-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-09-03 1998-03-05 1998-09-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-09-03 2002-03-05 2002-09-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag